{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:31:50Z","timestamp":1776285110003,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,29]]},"DOI":"10.7759\/cureus.63464","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T14:21:12Z","timestamp":1719670872000},"source":"Crossref","is-referenced-by-count":3,"title":["Exploring the Link Between Metabolic Syndrome and Cellulite"],"prefix":"10.7759","author":[{"given":"Nikos","family":"Adamidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Papalexis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Adamidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.151092","article-title":"Metabolic syndrome pandemic","volume":"28","author":"Grundy SM","year":"2008","unstructured":"Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008, 28:629-636. 10.1161\/ATVBAHA.107.151092","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2000.00016.x","article-title":"Cellulite: a review","volume":"14","author":"Rossi AB","year":"2000","unstructured":"Rossi AB, Vergnanini AL. Cellulite: a review. J Eur Acad Dermatol Venereol. 2000, 14:251-262. 10.1046\/j.1468-3083.2000.00016.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome \u2014 a new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti KG","year":"2006","unstructured":"Alberti KG, Zimmet P, Shaw J. Metabolic syndrome \u2014 a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006, 23:469-480. 10.1111\/j.1464-5491.2006.01858.x","journal-title":"Diabet Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2018.09.002","article-title":"Treatment for cellulite","volume":"5","author":"Sadick N","year":"2019","unstructured":"Sadick N. Treatment for cellulite. Int J Womens Dermatol. 2019, 5:68-72. 10.1016\/j.ijwd.2018.09.002","journal-title":"Int J Womens Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford ES","year":"2002","unstructured":"Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287:356-359. 10.1001\/jama.287.3.356","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-006-0351-5","article-title":"Gender differences in the metabolic syndrome and their role for cardiovascular disease","volume":"95","author":"Regitz-Zagrosek V","year":"2006","unstructured":"Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol. 2006, 95:136-147. 10.1007\/s00392-006-0351-5","journal-title":"Clin Res Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy SM","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al.. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005, 112:2735-2752. 10.1161\/CIRCULATIONAHA.105.169404","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03101.x","article-title":"A validated photonumeric cellulite severity scale","volume":"23","author":"Hexsel DM","year":"2009","unstructured":"Hexsel DM, Dal'forno T, Hexsel CL. A validated photonumeric cellulite severity scale. J Eur Acad Dermatol Venereol. 2009, 23:523-528. 10.1111\/j.1468-3083.2009.03101.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-789X.2011.00907.x","article-title":"Genetic variants and the metabolic syndrome: a systematic review","volume":"12","author":"Povel CM","year":"2011","unstructured":"Povel CM, Boer JM, Reiling E, Feskens EJ. Genetic variants and the metabolic syndrome: a systematic review. Obes Rev. 2011, 12:952-967. 10.1111\/j.1467-789X.2011.00907.x","journal-title":"Obes Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000002388","article-title":"Insights into the pathophysiology of cellulite: a review","volume":"46 Suppl 1","author":"Bass LS","year":"2020","unstructured":"Bass LS, Kaminer MS. Insights into the pathophysiology of cellulite: a review. Dermatol Surg. 2020, 46 Suppl 1:S77-S85. 10.1097\/DSS.0000000000002388","journal-title":"Dermatol Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i25.3999","article-title":"Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis","volume":"29","author":"Pal SC","year":"2023","unstructured":"Pal SC, M\u00e9ndez-S\u00e1nchez N. Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis. World J Gastroenterol. 2023, 29:3999-4008. 10.3748\/wjg.v29.i25.3999","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155142","article-title":"Insulin: The master regulator of glucose metabolism","volume":"129","author":"Norton L","year":"2022","unstructured":"Norton L, Shannon C, Gastaldelli A, DeFronzo RA. Insulin: The master regulator of glucose metabolism. Metabolism. 2022, 129:155142. 10.1016\/j.metabol.2022.155142","journal-title":"Metabolism"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease","volume":"7","author":"Chait A","year":"2020","unstructured":"Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020, 7:22. 10.3389\/fcvm.2020.00022","journal-title":"Front Cardiovasc Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/983814","article-title":"Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions","volume":"2012","author":"Snel M","year":"2012","unstructured":"Snel M, Jonker JT, Schoones J, et al.. Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol. 2012, 2012:983814. 10.1155\/2012\/983814","journal-title":"Int J Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00532","article-title":"Mitochondrial (dys)function and insulin resistance: from pathophysiological molecular mechanisms to the impact of diet","volume":"10","author":"Sergi D","year":"2019","unstructured":"Sergi D, Naumovski N, Heilbronn LK, Abeywardena M, O'Callaghan N, Lionetti L, Luscombe-Marsh N. Mitochondrial (dys)function and insulin resistance: from pathophysiological molecular mechanisms to the impact of diet. Front Physiol. 2019, 10:532. 10.3389\/fphys.2019.00532","journal-title":"Front Physiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"10","author":"Zatterale F","year":"2019","unstructured":"Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, Beguinot F. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2019, 10:1607. 10.3389\/fphys.2019.01607","journal-title":"Front Physiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.11.057","article-title":"Inflammation and insulin resistance","volume":"582","author":"de Luca C","year":"2008","unstructured":"de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008, 582:97-105. 10.1016\/j.febslet.2007.11.057","journal-title":"FEBS Lett"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1221438","article-title":"Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies","volume":"10","author":"Das D","year":"2023","unstructured":"Das D, Shruthi NR, Banerjee A, Jothimani G, Duttaroy AK, Pathak S. Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies. Front Nutr. 2023, 10:1221438. 10.3389\/fnut.2023.1221438","journal-title":"Front Nutr"},{"key":"ref19","article-title":"Adiponectin: an adipokine with protective features against metabolic syndrome","volume":"18","author":"Esfahani M","year":"2015","unstructured":"Esfahani M, Movahedian A, Baranchi M, Goodarzi MT. Adiponectin: an adipokine with protective features against metabolic syndrome. Iran J Basic Med Sci. 2015, 18:430-442.","journal-title":"Iran J Basic Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.6064\/2012\/205027","article-title":"Stress in obesity and associated metabolic and cardiovascular disorders","volume":"2012","author":"Holvoet P","year":"2012","unstructured":"Holvoet P. Stress in obesity and associated metabolic and cardiovascular disorders. Scientifica (Cairo). 2012, 2012:205027. 10.6064\/2012\/205027","journal-title":"Scientifica (Cairo)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1089\/whr.2021.0119","article-title":"Adverse changes in body composition during the menopausal transition and relation to cardiovascular risk: a contemporary review","volume":"3","author":"Kodoth V","year":"2022","unstructured":"Kodoth V, Scaccia S, Aggarwal B. Adverse changes in body composition during the menopausal transition and relation to cardiovascular risk: a contemporary review. Womens Health Rep (New Rochelle). 2022, 3:573-581. 10.1089\/whr.2021.0119","journal-title":"Womens Health Rep (New Rochelle)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04622.x","article-title":"Cellulite's aetiology: a review","volume":"27","author":"de la Casa Almeida M","year":"2013","unstructured":"de la Casa Almeida M, Serrano CS, Rold\u00e1n JR, Rejano JJJ. Cellulite's aetiology: a review. J Eur Acad Dermatol Venereol. 2013, 27:273-278. 10.1111\/j.1468-3083.2012.04622.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojad050","article-title":"Cellulite: current understanding and treatment","volume":"5","author":"Gabriel A","year":"2023","unstructured":"Gabriel A, Chan V, Caldarella M, Wayne T, O'Rorke E. Cellulite: current understanding and treatment. Aesthet Surg J Open Forum. 2023, 5:ojad050. 10.1093\/asjof\/ojad050","journal-title":"Aesthet Surg J Open Forum"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco GA","year":"2020","unstructured":"Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, et al.. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020, 21:9739. 10.3390\/ijms21249739","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2018.77235","article-title":"Cellulite: a cosmetic or systemic issue? Contemporary views on the etiopathogenesis of cellulite","volume":"35","author":"Tokarska K","year":"2018","unstructured":"Tokarska K, Tokarski S, Wo\u017aniacka A, Sysa-J\u0119drzejowska A, Bogaczewicz J. Cellulite: a cosmetic or systemic issue? Contemporary views on the etiopathogenesis of cellulite. Postepy Dermatol Alergol. 2018, 35:442-446. 10.5114\/ada.2018.77235","journal-title":"Postepy Dermatol Alergol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2007.00312.x","article-title":"The pathogenesis of cellulite: a new concept","volume":"6","author":"Pugliese PT","year":"2007","unstructured":"Pugliese PT. The pathogenesis of cellulite: a new concept. J Cosmet Dermatol. 2007, 6:140-142. 10.1111\/j.1473-2165.2007.00312.x","journal-title":"J Cosmet Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2013.05.009","article-title":"Cellulite: advances in treatment: facts and controversies","volume":"31","author":"Emanuele E","year":"2013","unstructured":"Emanuele E. Cellulite: advances in treatment: facts and controversies. Clin Dermatol. 2013, 31:725-730. 10.1016\/j.clindermatol.2013.05.009","journal-title":"Clin Dermatol"},{"key":"ref28","article-title":"Quantitative model of cellulite: three-dimensional skin surface topography, biophysical characterization, and relationship to human perception","volume":"56","author":"Smalls LK","year":"2005","unstructured":"Smalls LK, Lee CY, Whitestone J, Kitzmiller WJ, Wickett RR, Visscher MO. Quantitative model of cellulite: three-dimensional skin surface topography, biophysical characterization, and relationship to human perception. J Cosmet Sci. 2005, 56:105-120.","journal-title":"J Cosmet Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2009.07.031","article-title":"Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome","volume":"314","author":"Maury E","year":"2010","unstructured":"Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010, 314:1-16. 10.1016\/j.mce.2009.07.031","journal-title":"Mol Cell Endocrinol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2004.12.003","article-title":"AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism","volume":"1","author":"Kahn BB","year":"2005","unstructured":"Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1:15-25. 10.1016\/j.cmet.2004.12.003","journal-title":"Cell Metab"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.17.7.1472","article-title":"Sex differences in visceral fat lipolysis and metabolic complications of obesity","volume":"17","author":"L\u00f6nnqvist F","year":"1997","unstructured":"L\u00f6nnqvist F, Th\u00f6rne A, Large V, Arner P. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol. 1997, 17:1472-1480. 10.1161\/01.atv.17.7.1472","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19063385","article-title":"Changes in skin microcirculation resulting from vibration therapy in women with cellulite","volume":"19","author":"Piotrowska A","year":"2022","unstructured":"Piotrowska A, Czerwi\u0144ska-Ledwig O, Stefa\u0144ska M, et al.. Changes in skin microcirculation resulting from vibration therapy in women with cellulite. Int J Environ Res Public Health. 2022, 19:3385. 10.3390\/ijerph19063385","journal-title":"Int J Environ Res Public Health"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-021-00414-z","article-title":"The genetics of obesity: from discovery to biology","volume":"23","author":"Loos RJ","year":"2022","unstructured":"Loos RJ, Yeo GS. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022, 23:120-133. 10.1038\/s41576-021-00414-z","journal-title":"Nat Rev Genet"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/14764170410003057","article-title":"Cellulite: a review of its physiology and treatment","volume":"6","author":"Avram MM","year":"2004","unstructured":"Avram MM. Cellulite: a review of its physiology and treatment. J Cosmet Laser Ther. 2004, 6:181-185. 10.1080\/14764170410003057","journal-title":"J Cosmet Laser Ther"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051290","article-title":"The role of adipokines in health and disease","volume":"11","author":"Clemente-Su\u00e1rez VJ","year":"2023","unstructured":"Clemente-Su\u00e1rez VJ, Redondo-Fl\u00f3rez L, Beltr\u00e1n-Velasco AI, et al.. The role of adipokines in health and disease. Biomedicines. 2023, 11:1290. 10.3390\/biomedicines11051290","journal-title":"Biomedicines"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13517","article-title":"Pathophysiology of cellulite: possible involvement of selective endotoxemia","volume":"24","author":"Kruglikov IL","year":"2023","unstructured":"Kruglikov IL, Scherer PE. Pathophysiology of cellulite: possible involvement of selective endotoxemia. Obes Rev. 2023, 24:e13517. 10.1111\/obr.13517","journal-title":"Obes Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur R","year":"2014","unstructured":"Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014, 94:355-382. 10.1152\/physrev.00030.2013","journal-title":"Physiol Rev"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2494.2006.00318.x","article-title":"Cellulite and its treatment","volume":"28","author":"Rawlings AV","year":"2006","unstructured":"Rawlings AV. Cellulite and its treatment. Int J Cosmet Sci. 2006, 28:175-190. 10.1111\/j.1467-2494.2006.00318.x","journal-title":"Int J Cosmet Sci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz R","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, et al.. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006, 91:4237-4245. 10.1210\/jc.2006-0178","journal-title":"J Clin Endocrinol Metab"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.18.6.0318","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif A","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997, 18:774-800. 10.1210\/edrv.18.6.0318","journal-title":"Endocr Rev"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro RS","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013, 98:4565-4592. 10.1210\/jc.2013-2350","journal-title":"J Clin Endocrinol Metab"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1210\/er.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review","volume":"30","author":"Palomba S","year":"2009","unstructured":"Palomba S, Falbo A, Zullo F, Orio F Jr. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2009, 30:1-50. 10.1210\/er.2008-0030","journal-title":"Endocr Rev"},{"key":"ref43","article-title":"Cellulite and fatty tissue microcirculation","volume":"14","author":"Curri SB","year":"1993","unstructured":"Curri SB. Cellulite and fatty tissue microcirculation. Cosmet Med. 1993, 14:25-34.","journal-title":"Cosmet Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1978.tb00416.x","article-title":"So-called cellulite: an invented disease","volume":"4","author":"N\u00fcrnberger F","year":"1978","unstructured":"N\u00fcrnberger F, M\u00fcller G. So-called cellulite: an invented disease. J Dermatol Surg Oncol. 1978, 4:221-229. 10.1111\/j.1524-4725.1978.tb00416.x","journal-title":"J Dermatol Surg Oncol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/nu12072060","article-title":"Might starvation-induced adaptations in muscle mass, muscle morphology and muscle function contribute to the increased urge for movement and to spontaneous physical activity in anorexia nervosa?","volume":"12","author":"Casper RC","year":"2020","unstructured":"Casper RC. Might starvation-induced adaptations in muscle mass, muscle morphology and muscle function contribute to the increased urge for movement and to spontaneous physical activity in anorexia nervosa?. Nutrients. 2020, 12:2060. 10.3390\/nu12072060","journal-title":"Nutrients"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-108X(199605)19:4<359::AID-EAT4>3.0.CO;2-K","article-title":"Use of percentiles for the body mass index in anorexia nervosa: diagnostic, epidemiological, and therapeutic considerations","volume":"19","author":"Hebebrand J","year":"1996","unstructured":"Hebebrand J, Himmelmann GW, Heseker H, Schafer H, Remschmidt H. Use of percentiles for the body mass index in anorexia nervosa: diagnostic, epidemiological, and therapeutic considerations. Int J Eat Disord. 1996, 19:359-369. 10.1002\/(SICI)1098-108X(199605)19:4&lt;359::AID-EAT4&gt;3.0.CO;2-K","journal-title":"Int J Eat Disord"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2013.04.014","article-title":"Long-term consequences of anorexia nervosa","volume":"75","author":"Meczekalski B","year":"2013","unstructured":"Meczekalski B, Podfigurna-Stopa A, Katulski K. Long-term consequences of anorexia nervosa. Maturitas. 2013, 75:215-220. 10.1016\/j.maturitas.2013.04.014","journal-title":"Maturitas"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1177\/0884533611427916","article-title":"Refeeding syndrome or refeeding hypophosphatemia: a systematic review of cases","volume":"27","author":"Skipper A","year":"2012","unstructured":"Skipper A. Refeeding syndrome or refeeding hypophosphatemia: a systematic review of cases. Nutr Clin Pract. 2012, 27:34-40. 10.1177\/0884533611427916","journal-title":"Nutr Clin Pract"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2509","article-title":"Postmenopausal hormone therapy: an Endocrine Society scientific statement","volume":"95","author":"Santen RJ","year":"2010","unstructured":"Santen RJ, Allred DC, Ardoin SP, et al.. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010, 95:s1-s66. 10.1210\/jc.2009-2509","journal-title":"J Clin Endocrinol Metab"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.15.11.1690","article-title":"Effects of exercise on insulin sensitivity in humans","volume":"15","author":"Devlin JT","year":"1992","unstructured":"Devlin JT. Effects of exercise on insulin sensitivity in humans. Diabetes Care. 1992, 15:1690-1693. 10.2337\/diacare.15.11.1690","journal-title":"Diabetes Care"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00562.x","article-title":"Fibrillin-rich microfibrils are reduced in photoaged skin. Distribution at the dermal-epidermal junction","volume":"112","author":"Watson RE","year":"1999","unstructured":"Watson RE, Griffiths CE, Craven NM, Shuttleworth CA, Kielty CM. Fibrillin-rich microfibrils are reduced in photoaged skin. Distribution at the dermal-epidermal junction. J Invest Dermatol. 1999, 112:782-787. 10.1046\/j.1523-1747.1999.00562.x","journal-title":"J Invest Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210338","article-title":"Effect of manual lymphatic drainage on the concentrations of selected adipokines, cytokines, C-reactive protein and parameters of carbohydrate and lipid metabolism in patients with abnormal body mass index: focus on markers of obesity and insulin resistance","volume":"24","author":"Antoniak-Pietrynczak K","year":"2023","unstructured":"Antoniak-Pietrynczak K, Zorena K, Jaskulak M, Hansdorfer-Korzon R, Kozi\u0144ski M. Effect of manual lymphatic drainage on the concentrations of selected adipokines, cytokines, C-reactive protein and parameters of carbohydrate and lipid metabolism in patients with abnormal body mass index: focus on markers of obesity and insulin resistance. Int J Mol Sci. 2023, 24:10338. 10.3390\/ijms241210338","journal-title":"Int J Mol Sci"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0129-5","article-title":"Cellulite: an evidence-based review","volume":"16","author":"Luebberding S","year":"2015","unstructured":"Luebberding S, Krueger N, Sadick NS. Cellulite: an evidence-based review. Am J Clin Dermatol. 2015, 16:243-256. 10.1007\/s40257-015-0129-5","journal-title":"Am J Clin Dermatol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12154","article-title":"Cellulite treatment: a comprehensive literature review","volume":"14","author":"Zerini I","year":"2015","unstructured":"Zerini I, Sisti A, Cuomo R, et al.. Cellulite treatment: a comprehensive literature review. J Cosmet Dermatol. 2015, 14:224-240. 10.1111\/jocd.12154","journal-title":"J Cosmet Dermatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1159\/000343174","article-title":"Caffeine's mechanisms of action and its cosmetic use","volume":"26","author":"Herman A","year":"2013","unstructured":"Herman A, Herman AP. Caffeine's mechanisms of action and its cosmetic use. Skin Pharmacol Physiol. 2013, 26:8-14. 10.1159\/000343174","journal-title":"Skin Pharmacol Physiol"},{"key":"ref56","unstructured":"SCIENTIFIC PROGRAM - 7th Congress of the European Society of Diabetes, Metabolic Syndrome &amp; Obesity. (2021). https.\/\/esodimeso.com\/2021\/scprogram\/."},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03556.x","article-title":"A multilocus candidate approach identifies ACE and HIF1A as susceptibility genes for cellulite","volume":"24","author":"Emanuele E","year":"2010","unstructured":"Emanuele E, Bertona M, Geroldi D. A multilocus candidate approach identifies ACE and HIF1A as susceptibility genes for cellulite. J Eur Acad Dermatol Venereol. 2010, 24:930-935. 10.1111\/j.1468-3083.2009.03556.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04713.x","article-title":"Adiponectin expression in subcutaneous adipose tissue is reduced in women with cellulite","volume":"50","author":"Emanuele E","year":"2011","unstructured":"Emanuele E, Minoretti P, Altabas K, Gaeta E, Altabas V. Adiponectin expression in subcutaneous adipose tissue is reduced in women with cellulite. Int J Dermatol. 2011, 50:412-416. 10.1111\/j.1365-4632.2010.04713.x","journal-title":"Int J Dermatol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031012","article-title":"Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation","volume":"89","author":"Tan KC","year":"2004","unstructured":"Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, Lam KS. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab. 2004, 89:765-769. 10.1210\/jc.2003-031012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1042\/CS20040190","article-title":"The role of insulin and the adipocytokines in regulation of vascular endothelial function","volume":"107","author":"Ritchie SA","year":"2004","unstructured":"Ritchie SA, Ewart MA, Perry CG, Connell JM, Salt IP. The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin Sci (Lond). 2004, 107:519-532. 10.1042\/CS20040190","journal-title":"Clin Sci (Lond)"},{"key":"ref61","article-title":"Adipocytokines \u2014 novel link between inflammation and vascular function?","volume":"57","author":"Guzik TJ","year":"2006","unstructured":"Guzik TJ, Mangalat D, Korbut R. Adipocytokines \u2014 novel link between inflammation and vascular function?. J Physiol Pharmacol. 2006, 57:505-528.","journal-title":"J Physiol Pharmacol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang PL","year":"2009","unstructured":"Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009, 2:231-237. 10.1242\/dmm.001180","journal-title":"Dis Model Mech"},{"key":"ref63","article-title":"Adipocytokines\u2014proteins of multidirectional function","volume":"3","author":"Jasi\u0144ska A","year":"2010","unstructured":"Jasi\u0144ska A, Pietruczuk M. Adipocytokines\u2014proteins of multidirectional function. Diagn Lab. 2010, 3:331-338.","journal-title":"Diagn Lab"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.5604\/17322693.997817","article-title":"Leptin as a mediator between obesity and cardiac dysfunction","volume":"66","author":"Karbowska J","year":"2012","unstructured":"Karbowska J, Kochan Z. Leptin as a mediator between obesity and cardiac dysfunction. Postepy Hig Med Dosw (Online). 2012, 66:267-274. 10.5604\/17322693.997817","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.00966.x","article-title":"The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome \u2014 a randomised, double-blind, placebo-controlled trial","volume":"113","author":"Lord J","year":"2006","unstructured":"Lord J, Thomas R, Fox B, Acharya U, Wilkin T. The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome \u2014 a randomised, double-blind, placebo-controlled trial. BJOG. 2006, 113:817-824. 10.1111\/j.1471-0528.2006.00966.x","journal-title":"BJOG"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0846.2004.00072.x","article-title":"Pilot study of dermal and subcutaneous fat structures by MRI in individuals who differ in gender, BMI, and cellulite grading","volume":"10","author":"Mirrashed F","year":"2004","unstructured":"Mirrashed F, Sharp JC, Krause V, Morgan J, Tomanek B. Pilot study of dermal and subcutaneous fat structures by MRI in individuals who differ in gender, BMI, and cellulite grading. Skin Res Technol. 2004, 10:161-168. 10.1111\/j.1600-0846.2004.00072.x","journal-title":"Skin Res Technol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3136\/islsm.22.131","article-title":"Ultrastructural assessment of cellulite morphology: clues to a therapeutic strategy?","volume":"22","author":"Omi T","year":"2013","unstructured":"Omi T, Sato S, Kawana S. Ultrastructural assessment of cellulite morphology: clues to a therapeutic strategy?. Laser Ther. 2013, 22:131-136. 10.3136\/islsm.22.131","journal-title":"Laser Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/267058-exploring-the-link-between-metabolic-syndrome-and-cellulite","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T14:21:20Z","timestamp":1719670880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/267058-exploring-the-link-between-metabolic-syndrome-and-cellulite"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":67,"URL":"https:\/\/doi.org\/10.7759\/cureus.63464","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,29]]}}}